enVVeno Medical Corporation (NVNO)
NASDAQ: NVNO · Real-Time Price · USD
2.740
+0.010 (0.37%)
Apr 25, 2025, 4:00 PM EDT - Market closed
enVVeno Medical Revenue
Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
37
Market Cap
47.96M
Revenue Chart
Revenue History
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 410.06B |
Johnson & Johnson | 89.33B |
Merck & Co. | 63.92B |
AbbVie | 56.33B |
AstraZeneca | 54.07B |
Novartis AG | 51.72B |
Eli Lilly and Company | 45.04B |
Thermo Fisher Scientific | 42.90B |
NVNO News
- 4 days ago - VenoValve to be Featured During Presentation at the 47th Annual Charing Cross Symposium - Accesswire
- 11 days ago - enVVeno Medical to Participate in a Live Virtual Investor Closing Bell Segment - Accesswire
- 27 days ago - The Impact of the VenoValve(R) on Patients with Primary and Secondary Chronic Venous Insufficiency (CVI) to be Presented at the Society for Clinical Vascular Surgery 52nd Annual Symposium - Accesswire
- 2 months ago - enVVeno Medical Reports Fourth Quarter and Year-End 2024 Financial Results and Progress Towards VenoValve FDA Approval Expected in 2H25 - Accesswire
- 2 months ago - enVVeno Medical Participates in the Virtual Investor “Top 5 for ‘25” On-Demand Conference - Accesswire
- 2 months ago - One-Year Data from the VenoValve(R) U.S. Pivotal Trial Highlighting Impact on Patients' Quality of Life (QOL) to be Presented Today at the 37th Annual Meeting of the American Venous Forum - Accesswire
- 2 months ago - Interim Two-Year Follow-Up Data from the VenoValve(R) U.S. Pivotal Trial to be Presented Today at the VESS 2025 Annual Winter Meeting - Accesswire
- 4 months ago - enVVeno Medical Successfully Completes Final Wave of Implants in Pre-Clinical GLP Study for enVVe - Accesswire